TNDM

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a medical device company founded in 2006 and headquartered in San Diego, California. The company was originally incorporated as Phluid Inc. before changing its name to Tandem Diabetes Care in January 2008 and went public in November 2013. Tandem specializes in designing, developing, and commercializing insulin delivery systems for people with insulin-dependent diabetes, primarily focusing on Type 1 diabetes patients but expanding into the Type 2 diabetes market. The company has grown to serve over 460,000 customers worldwide and has established itself as a significant player in the automated insulin delivery market through its flagship <b>t:slim X2</b> pump platform and innovative <b>Control-IQ</b> technology.